AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.

A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...

Hospitals are up in arms over new guidance issued by the Health Resources and Services Administration on Thursday that could restrict the eligibility of their outpatient clinics for drug discounts in ...

The 340B Drug Pricing Program (340B program) is a federal drug discount program that requires drug manufacturers participating in the Medicaid drug rebate program to provide outpatient drugs to ...

Stitt and other Republican governors argue that drug discounts can be used to support abortion services indirectly.

Americans assume hospitals are in the business of keeping us healthy, not of buying drugs inexpensively and then reselling ...

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...

Hospitals and small organizations should have equal levels of oversight and scrutiny. One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and ...

Republican governors, including Gov. Kevin Stitt, urge HRSA to revoke Planned Parenthood's eligibility for the 340B program.